Research
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis
BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b92 (Published 16 February 2009) Cite this as: BMJ 2009;338:b92Related articles
- Editorial Published: 16 February 2009; BMJ 338 doi:10.1136/bmj.a3065
- Education And Debate Published: 28 July 2005; BMJ 331 doi:10.1136/bmj.331.7511.281
- Research Published: 22 February 2011; BMJ 342 doi:10.1136/bmj.d636
- Research Published: 07 January 2013; BMJ 346 doi:10.1136/bmj.e8539
- Research Published: 10 July 2014; BMJ 349 doi:10.1136/bmj.g4164
See more
- Sixty seconds on . . . 10 000 stepsBMJ March 08, 2024, 384 q598; DOI: https://doi.org/10.1136/bmj.q598
- Scarlett McNally: Enabling active travel can improve the UK’s healthBMJ March 06, 2024, 384 q522; DOI: https://doi.org/10.1136/bmj.q522
- Scarlett McNally: Boosting swimming for health and joyBMJ February 20, 2024, 384 q393; DOI: https://doi.org/10.1136/bmj.q393
- Variability in blood pressure could help predict heart attack and stroke risk, researchers sayBMJ February 09, 2024, 384 q363; DOI: https://doi.org/10.1136/bmj.q363
- Scarlett McNally: Preventing obesity is different from curing it—and even more urgentBMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134
Cited by...
- Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons
- High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III and Subclinical Atherosclerosis Measures: MESA (The Multi-Ethnic Study of Atherosclerosis)
- Surrogate disease markers as substitutes for chronic disease outcomes in studies of diet and chronic disease relations
- Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys
- A New Frontier for Reverse Cholesterol Transport: The Impact of Intestinal Microbiota on Reverse Cholesterol Transport
- General practitioners justifications for therapeutic inertia in cardiovascular prevention: an empirically grounded typology
- Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk?: CETP as a Target to Lower CVD Risk: Suspension of Disbelief?
- Clinical benefit from pharmacological elevation of high-density lipoprotein cholesterol: meta-regression analysis
- Insulin Resistance and Risk of Cardiovascular Disease in Postmenopausal Women: A Cohort Study From the Women's Health Initiative
- HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export
- Quantification of HDL Proteins, Cardiac Events, and Mortality in Patients with Type 2 Diabetes on Hemodialysis
- Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data
- Approach to identifying and managing atherogenic dyslipidemia: A metabolic consequence of obesity and diabetes
- Facons d'identifier et de prendre en charge la dyslipidemie atherogene: Une consequence metabolique de l'obesite et du diabete
- Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis
- In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1
- Maternal Cardiovascular Risk Profile After Placental Abruption
- Diesel Exhaust Induces Systemic Lipid Peroxidation and Development of Dysfunctional Pro-Oxidant and Pro-Inflammatory High-Density Lipoprotein
- MCP-1 impacts RCT by repressing ABCA1, ABCG1, and SR-BI through PI3K/Akt posttranslational regulation in HepG2 cells
- Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low-HDL Phenotype
- Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies
- ABCA1-dependent serum cholesterol efflux capacity inversely correlates with pulse wave velocity in healthy subjects
- Dysfunctional High-Density Lipoprotein in Patients on Chronic Hemodialysis
- Association Between Changes in Lipid Profiles and Progression of Symptomatic Intracranial Atherosclerotic Stenosis: A Prospective Multicenter Study
- HDL Mimetics Inhibit Tumor Development in Both Induced and Spontaneous Mouse Models of Colon Cancer
- Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease
- On-Treatment Non-High-Density Lipoprotein Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk After Treatment With Potent Statin Therapy: JUPITER (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)
- Alcohol and the Heart: Does Raising High-Density Lipoprotein Matter?
- Controlling for High-Density Lipoprotein Cholesterol Does Not Affect the Magnitude of the Relationship Between Alcohol and Coronary Heart Disease
- Diabetes and Cardiovascular Disease: When it comes to lipids, statins are all you need
- HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events
- Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies
- Newer antiatherosclerosis treatment strategies
- Carotid Ultrasound, Coronary Calcium, and Dyslipidemia Patterns in the MESA (Multi-Ethnic Study of Atherosclerosis) Cohort
- High-density lipoprotein cholesterol increase and non-cardiovascular mortality: a meta-analysis
- Raising high-density lipoprotein: for better or worse?
- High Pre-{beta}1 HDL Concentrations and Low Lecithin: Cholesterol Acyltransferase Activities Are Strong Positive Risk Markers for Ischemic Heart Disease and Independent of HDL-Cholesterol
- Low High-Density Lipoprotein Cholesterol and Chronic Disease Risk: Marker or Causal?
- Cardiovascular and Overall Mortality Risk in Relation to Alcohol Consumption in Patients With Cardiovascular Disease
- Which lipid fraction is the target and how often should this be monitored?
- Structure and Function of HDL Mimetics
- Are You Targeting Non-High-Density Lipoprotein Cholesterol?
- HDL as a Biomarker, Potential Therapeutic Target, and Therapy
- HDL Levels and Coronary Heart Disease: It's Complicated
- Treatment-Mediated Change in HDL Cholesterol Levels and CHD Risks
- HDL cholesterol and cardiovascular risk